DOJ Going After Drug Makers in Opioid Epidemic Fight

The Department of Justice (DOJ) will form a task force to go after drug companies that have contributed to the opioid crisis by overselling the prescription painkillers. In a press conference Tuesday, Attorney General Jeff Sessions discussed how the new Prescription Interdiction & Litigation Task Force plans to combat the drug epidemic.

“This epidemic actually lowered American life expectancy in 2015 and 2016 for the first time in decades, with drug overdose now the leading cause of death for Americans under age 50,” Sessions said.

The DOJ has vowed to use all criminal and civil tools to hold distributors such as pharmacies, pain management clinics, drug testing facilities and doctors accountable for engaging in unlawful activity involving prescription opioids. The DOJ will review legislative and regulatory changes in existing laws, as well as current state and local government lawsuits against opioid manufacturers, to see whether the department can be of any help


Alanna McCatty

Alanna McCatty

Alanna McCatty is founder and CEO of McCatty Scholars, an organization that devises and implements financial literacy programs for students to combat the nationwide issue of the loss of educational opportunity due to the ramifications of burdensome student debt. At MedShadow, she reports on new findings and research on the side effects of prescription drugs. She is a graduate of Pace University.


Did you find this article helpful?


Latest News

Beware of Fake COVID-19 Treatments 

Beware of Fake COVID-19 Treatments 

Lots of internet ads are promising to prevent, treat or cure COVID-19. Here’s the truth on Vitamin C, zinc and colloidal silver.

  • Advertisement